Mesalamine Suppository
NDC Package 70710-1302-7
Package Information
Mesalamine suppositories is a medication used to treat a certain bowel disease (ulcerative colitis). This formulation utilizes a suppository delivery system. Marketed by Zydus Pharmaceuticals Usa Inc., this product is identified by NDC 70710-1302 and is authorized under FDA application ANDA208953.
Identification & Billing
- RxCUI: 248420 - mesalamine 1000 MG Rectal Suppository
- RxCUI: 248420 - mesalazine 1000 MG Rectal Suppository
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70710 - Zydus Pharmaceuticals Usa Inc.
- 70710-1302 - Mesalamine
- 70710-1302-7 - 5 BLISTER PACK in 1 POUCH / 6 SUPPOSITORY in 1 BLISTER PACK (70710-1302-6)
- 70710-1302 - Mesalamine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70710-1302-7 identifies a specific commercial package of 5 blister pack in 1 pouch / 6 suppository in 1 blister pack (70710-1302-6) of Mesalamine, a human prescription drug labeled by Zydus Pharmaceuticals Usa Inc.. This suppository is formulated for rectal use and contains mesalamine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Pharmaceuticals Usa Inc. on February 14, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain. Mesalamine belongs to a class of drugs known as aminosalicylates. It works by decreasing swelling in the colon.
How is this Zydus Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70710130207. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.